Publications

Filter Publications By:

Encorafenib / Cancer

04/11/2014

HemOnc Today: Melanoma and Cutaneous Malignancies, April 11-12, 2014, New York, NY

The Development of Encorafenib (LGX818) and Binimetinib (MEK162) in Patients With Metastatic Melanoma

R. Dummer, et. al

ARRY-502 / Asthma

03/01/2014

American Academy of Allergy, Asthma & Immunology Annual Meeting

Safety and Efficacy of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, in Patients with Mild to Moderate Th2-Driven Asthma

S. Wenzel, et al.

Filanesib / Multiple Myeloma

12/09/2013

American Society of Hematology Annual Meeting

Prolonged Survival and Improved Response Rates with ARRY-520 in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with Low Alpha-1 Acid Glycoprotein (AAG) levels: Results from a Phase 2 Study

S. Lonial, M.D. et al.

ARRY-614 / MDS

12/09/2013

American Society of Hematology Annual Meeting

Phase 1 Dose-Escalation/Expansion Study of ARRY-614 in Patients with IPSS Low/Int-1 Risk Myelodysplastic Syndromes

G. Garcia-Manero, et al.

Filanesib / Multiple Myeloma

12/08/2013

American Society of Hematology Annual Meeting

ARRY-520 Combined with Pomalidomide Displays Enhanced Anti-Tumor Activity in Preclinical Models of Multiple Myeloma

M. J. Humphries, et al.

Filanesib / Multiple Myeloma

12/07/2013

American Society of Hematology Annual Meeting

A Phase 1 Study of ARRY-520 (Filanesib) with Bortezomib in Relapsed or Refractory Multiple Myeloma

A. Chari, M.D., et al.

Filanesib / Multiple Myeloma

12/07/2013

American Society of Hematology Annual Meeting

Phase I Study of the Novel Kinesin Spindle Protein Inhibitor Filanesib (ARRY-520) + Carfilzomib (Car) in Patients with Relapsed and/or Refractory Multiple Myeloma

J.J. Shah, MD, et al.

ARRY-382 / CSF1R

11/01/2013

EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

A Phase 1 Study of ARRY-382, an Oral Inhibitor of Colony-stimulating Factor-1 Receptor (CSF1R), in Patients with Advanced or Metastatic Cancers

J. Bendell, M.D., et al.

Filanesib / Multiple Myeloma

10/16/2013

International Society for the Study of Xenobiotics International Meeting

The Role of Alpha 1-Acid Glycoprotein (AAG) as a Selection Marker for ARRY-520 Exposure

K. D. Brown, et al.

ARRY-380 / Breast Cancer

10/07/2013

American Association for Cancer Research Special Conference on Advances in Breast Cancer Research

ONT-380 (ARRY-380) - an Oral HER2 Inhibitor - Final Phase 1 Results and Conclusions

V. F. Borges, et al.